{
  "AuthorID": "SuzieP",
  "AuthorURL": "https://community.breastcancer.orghttps://community.breastcancer.org/member/228468/profile",
  "Posts": [{
    "AuthorID": "SuzieP",
    "AuthorURL": "https://community.breastcancer.orghttps://community.breastcancer.org/member/228468/profile",
    "Content": "SuzieP wrote: A recent biopsy on tissue taken from my iliac has tested ER-, PR-, HER2+ My original breast cancer tumor was ER+, PR+, HER2- I had widespread bone mets recently and now the Ibrance and faslodex I just started will be discontinued and something else will begin. Please weigh in if this has happened to you - having your tumor chemistry change through metastases Thank you! Dx 3/2008, IDC, Left, 6cm+, Stage IIIB, metastasized to bone, Grade 3, 1/12 nodes, ER+/PR+, HER2- Dx 3/2014, IDC, Left, Stage IV, metastasized to bone Dx 2/5/2016, Stage IV, metastasized to bone Hormonal Therapy 2/7/2016 Faslodex (fulvestrant) Targeted Therapy 2/7/2016 Ibrance (palbociclib) Dx 2/20/2016, Stage IV, ER-/PR-, HER2+ Hormonal Therapy Femara (letrozole) Chemotherapy AC + T (Taxol) Hormonal Therapy Hormonal Therapy Tamoxifen pills (Nolvadex, Apo-Tamox, Tamofen, Tamone) Radiation Therapy External: Bone Log in to post a reply",
    "MessageIndex": 0,
    "PostDate": "25/02/2016",
    "ThreadURL": "https://community.breastcancer.org/forum/8/topics/841629",
    "Title": "Hormone Receptor and HER2 changes for Mets SuzieP Mzmerz"
  }]
}